These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18818403)

  • 1. The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation.
    Gizard F; Nomiyama T; Zhao Y; Findeisen HM; Heywood EB; Jones KL; Staels B; Bruemmer D
    Circ Res; 2008 Nov; 103(10):1155-63. PubMed ID: 18818403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways of proliferation: new targets to inhibit the growth of vascular smooth muscle cells.
    Marsboom G; Archer SL
    Circ Res; 2008 Nov; 103(10):1047-9. PubMed ID: 18988899
    [No Abstract]   [Full Text] [Related]  

  • 3. PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.
    Gizard F; Amant C; Barbier O; Bellosta S; Robillard R; Percevault F; Sevestre H; Krimpenfort P; Corsini A; Rochette J; Glineur C; Fruchart JC; Torpier G; Staels B
    J Clin Invest; 2005 Nov; 115(11):3228-38. PubMed ID: 16239970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
    Ogawa D; Nomiyama T; Nakamachi T; Heywood EB; Stone JF; Berger JP; Law RE; Bruemmer D
    Circ Res; 2006 Apr; 98(7):e50-9. PubMed ID: 16556873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K; Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
    Ausserlechner MJ; Obexer P; Geley S; Kofler R
    Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis.
    Simpson DS; Mason-Richie NA; Gettler CA; Wikenheiser-Brokamp KA
    Cancer Res; 2009 Nov; 69(22):8733-41. PubMed ID: 19887614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inorganic arsenic exposure induces E2F-dependent G0/G1 arrest via an increase in retinoblastoma family protein p130 in B-cell lymphoma A20 cells.
    Okamura K; Miki D; Nohara K
    Genes Cells; 2013 Oct; 18(10):839-49. PubMed ID: 23890198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.
    Lin PS; McPherson LA; Chen AY; Sage J; Ford JM
    DNA Repair (Amst); 2009 Jul; 8(7):795-802. PubMed ID: 19376752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A/Rb/E2F1 and JNK signaling pathways.
    Ding L; Li L; Yang J; Zhou S; Li W; Tang M; Shi Y; Yi W; Cao Y
    J Med Virol; 2007 Aug; 79(8):1153-63. PubMed ID: 17597480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
    Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
    Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
    Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway.
    Sun A; Bagella L; Tutton S; Romano G; Giordano A
    J Cell Biochem; 2007 Dec; 102(6):1400-4. PubMed ID: 17979151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.
    Ng VY; Morisseau C; Falck JR; Hammock BD; Kroetz DL
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2462-8. PubMed ID: 16917105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low p16
    Graham MK; Principessa L; Antony L; Meeker AK; Isaacs JT
    Prostate; 2017 Mar; 77(4):374-384. PubMed ID: 27859428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase Reverse Transcriptase Deficiency Prevents Neointima Formation Through Chromatin Silencing of E2F1 Target Genes.
    Endorf EB; Qing H; Aono J; Terami N; Doyon G; Hyzny E; Jones KL; Findeisen HM; Bruemmer D
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):301-311. PubMed ID: 27932351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iroquois homeobox transcription factor (Irx5) promotes G1/S-phase transition in vascular smooth muscle cells by CDK2-dependent activation.
    Liu D; Pattabiraman V; Bacanamwo M; Anderson LM
    Am J Physiol Cell Physiol; 2016 Aug; 311(2):C179-89. PubMed ID: 27170637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.